Demystified...recombinant antibodies

Journal of Clinical Pathology
K A SmithJ Greenman

Abstract

Recombinant antibodies are important tools for biomedical research and are increasingly being used as clinical diagnostic/therapeutic reagents. In this article, a background to humanized antibodies is given, together with details of the generation of antibody fragments--for example, single chain Fv fragments. Phage antibody fragments are fast becoming popular and can be generated by simple established methods of affinity enrichment from libraries derived from immune cells. Phage display methodology can also be used for the affinity enrichment of existing antibody fragments to provide a reagent with a higher affinity. Here, phage antibodies are demystified to provide a greater understanding of the potential of these reagents and to engage clinicians and biomedical scientists alike to think about potential applications in pathology and clinical settings.

References

Jan 1, 1994·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·M B KhazaeliA F LoBuglio
Nov 4, 1996·International Journal of Cancer. Journal International Du Cancer·B CarnemollaL Zardi
Jul 14, 1998·Immunotechnology : an International Journal of Immunological Engineering·H R HoogenboomR C Roovers
May 4, 1999·FEMS Immunology and Medical Microbiology·P Williamson, R Matthews
Jul 18, 2000·Molecular Pathology : MP·P N NelsonP G Murray
Aug 1, 2000·Immunology Today·H R Hoogenboom, P Chames
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·J TordssonT Brodin
Aug 15, 2000·Cancer Immunology, Immunotherapy : CII·S ReinartzD Wallwiener
Aug 19, 2000·Cancer Chemotherapy and Pharmacology·K A ChesterR H Begent
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A KarpasB H Czepulkowski
Apr 24, 2001·Cancer Immunology, Immunotherapy : CII·R C RooversH R Hoogenboom
Jan 22, 2003·Biochemical and Biophysical Research Communications·Ling DongMelitta Schachner
Feb 1, 2003·Molecular Pathology : MP·P N NelsonP G Murray
Mar 1, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Thierry Lacaze-MasmonteilUNKNOWN Second Season Safety Study Group
Mar 26, 2003·Biochemical Society Transactions·L H Stockwin, S Holmes
Mar 29, 2003·Expert Opinion on Biological Therapy·Christelle Souriau, Peter J Hudson
Mar 29, 2003·Expert Opinion on Biological Therapy·Gennaro D'Amato
Jul 11, 2003·Immunology Letters·Paul N NelsonFrank C Hay

❮ Previous
Next ❯

Citations

Oct 1, 2008·Histochemistry and Cell Biology·Paul Debbage, Werner Jaschke
Sep 2, 2005·Nature·John L VandeBerg, Stuart M Zola
May 22, 2009·Journal of Proteomics·G P Espino-SolisL D Possani
Sep 21, 2010·Human Immunology·Ali ElbakriRaed O Abu Odeh
Mar 5, 2010·The Journal of Allergy and Clinical Immunology·Harry W Schroeder, Lisa Cavacini
Nov 6, 2007·Biochimica Et Biophysica Acta·Ying-Fang YangTzu-Ling Tseng
Apr 4, 2006·Lancet·Colin H Self, Stephen Thompson
Jan 6, 2006·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·G J ThomasJ F Marshall
Dec 11, 2019·The Journal of Biological Chemistry·Lakshmi Pillai-KastooriAmy R Schutz-Geschwender
Nov 5, 2008·Expert Review of Vaccines·Kathryn Sykes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Related Papers

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
D L Siegel
Current Opinion in Biotechnology
C F Barbas
Molecular Therapy : the Journal of the American Society of Gene Therapy
Todd W Miller, Anne Messer
Acta Pharmacologica Sinica
Jonathan S Marvin, Zhenping Zhu
© 2021 Meta ULC. All rights reserved